These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations. Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045 [TBL] [Abstract][Full Text] [Related]
4. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons. Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889 [TBL] [Abstract][Full Text] [Related]
5. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084 [TBL] [Abstract][Full Text] [Related]
6. Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons. Graef JD; Wu H; Ng C; Sun C; Villegas V; Qadir D; Jesseman K; Warren ST; Jaenisch R; Cacace A; Wallace O Eur J Neurosci; 2020 May; 51(10):2143-2157. PubMed ID: 31880363 [TBL] [Abstract][Full Text] [Related]
7. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth. Doers ME; Musser MT; Nichol R; Berndt ER; Baker M; Gomez TM; Zhang SC; Abbeduto L; Bhattacharyya A Stem Cells Dev; 2014 Aug; 23(15):1777-87. PubMed ID: 24654675 [TBL] [Abstract][Full Text] [Related]
8. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients. Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome. Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763 [TBL] [Abstract][Full Text] [Related]
10. FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation. Jiraanont P; Zafarullah M; Sulaiman N; Espinal GM; Randol JL; Durbin-Johnson B; Schneider A; Hagerman RJ; Hagerman PJ; Tassone F J Mol Diagn; 2024 Jun; 26(6):498-509. PubMed ID: 38522837 [TBL] [Abstract][Full Text] [Related]
11. Human pluripotent stem cell models of Fragile X syndrome. Bhattacharyya A; Zhao X Mol Cell Neurosci; 2016 Jun; 73():43-51. PubMed ID: 26640241 [TBL] [Abstract][Full Text] [Related]
12. Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers. Gustin SLF; Wang G; Baker VM; Latham G; Sebastiano V J Assist Reprod Genet; 2018 Aug; 35(8):1443-1455. PubMed ID: 29926373 [TBL] [Abstract][Full Text] [Related]
13. microRNAs and Fragile X Syndrome. Lin SL Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181 [TBL] [Abstract][Full Text] [Related]
14. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622 [TBL] [Abstract][Full Text] [Related]
15. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation. Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability to medication management: an update on fragile X syndrome. Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260 [TBL] [Abstract][Full Text] [Related]
17. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays. Sølvsten C; Nielsen AL Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618 [TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome full mutation in cognitively normal male identified as part of an Australian reproductive carrier screening program. Jarmolowicz AI; Baker EK; Bartlett E; Francis D; Ling L; Gamage D; Delatycki MB; Godler DE Am J Med Genet A; 2021 May; 185(5):1498-1503. PubMed ID: 33544979 [TBL] [Abstract][Full Text] [Related]
19. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome. Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828 [TBL] [Abstract][Full Text] [Related]
20. Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome. Randol JL; Kim K; Ponzini MD; Tassone F; Falcon AK; Hagerman RJ; Hagerman PJ Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]